You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

May 13, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Hep C cases driving opioid abuse

Hepatitis C infections are soaring in 4 states because of high rates of opioid abuse, according to a new report from the Centers for Disease Control and Prevention (CDC). » Is your state one of them?

New forum expands access to biosimilars

The need for credible, sustained, and unbiased biosimilars education has fueled the development of the Biosimilars Forum. » Key stakeholders involved

Continuing Education

MTM essentials for asthma management: Part 2

This month's CE activity is part of the CE series, MTM for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the stepwise approach to the management of pediatric and adult asthma and the pharmacotherapies commonly used in asthma treatment.

To read and print the article with TEST questions, click here

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT30-PYJ23.


Announcement: The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration has been uploaded for your convenience. Current users do not need to register. To review you registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Oncology drug spending soars

The increased prevalence of most cancers, earlier treatment initiation, new medicines and improved outcomes are all contributing to the greater demand for oncology therapeutics around the world. » How this demand is driving costs

 

RELATED ARTICLES

FDA approves changes to hep C drug label to include new warnings

Adoption of fast-growing biosimilars segment essential

RESOURCES

Latest Clinical News

Powered by Modern Medicine UBM  logo

UBM MEDICA